Jakob Lovén Joins Persomics Board

Share Article

Jakob Lovén (Third Rock Ventures, Relay Therapeutics, Syros Pharmaceuticals) joins Persomics board to help guide the current product line to launch and provide strategic direction in extending the Persomics ImagineArray™ platform.

Jakob will help guide Persomics current product line to launch, and will be a tremendous asset in further expanding Persomics' platform as a tool for functional genomics research and beyond. (Martin Svensson, CEO)

Jakob Lovén is an accomplished R&D scientist and entrepreneur with extensive experience in building early-stage therapeutic-based platform companies. After earning a BA in Natural Sciences at the University of Cambridge, and a Ph.D. in Medical Sciences from Karolinska Institutet in Stockholm, Sweden, Jakob went on to a post-doctoral fellowship at the Young Lab at MIT's Whitehead Institute for Biomedical Research. He was later a founding scientist of Syros Pharmaceuticals, where he established and led the R&D and platform development efforts to support drug discovery initiatives in oncology and non-oncology indications. Currently Jakob is responsible for managing strategic direction, growth, and partnerships at Relay Therapeutics, a company he co-founded as Senior Associate at Third Rock Ventures.

“Jakob brings a visionary mindset to Persomics. He has a deep understanding of both the scientific and technological foundation of the Persomics platform, coupled with a proven ability to build science-based organizations in the U.S. Jakob will help guide Persomics current product line to launch, and will be a tremendous asset in further expanding Persomics' platform as a tool for functional genomics research and beyond.” – Martin Svensson, Persomics CEO

"The power of Persomics' platform lies in its simplicity. Persomics has managed to simplify phenotypic screening by developing user-friendly, highly miniaturized functional genomic assays across many applications. There is great potential in this platform and how the technology can be purposed beyond its current scope. Applications are not necessarily limited to functional genomics – I see a wider opportunity for developing the platform as a general tool for understanding and engineering cell behavior." – Jakob Lovén

Jakob is a mentor to several biotech startups in the Boston area and is a Senior Advisor on the Swedish American Chamber of Commerce Life Science Accelerator.

Jakob Lovén has joined the Persomics board as of June 1, 2016, and will initially focus on strengthening the long-term strategic planning of the company.

Please see contact info for further inquiries.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Martin Svensson
Persomics
+1 (617) 467-8896
Email >

Jakob Lovén
Visit website